P354 Tryptophan metabolites as predictive biomarkers for dietary therapy outcomes in paediatric Crohn's disease
Mohammed Ghiboub(Amsterdam UMC Location University of Amsterdam), Johan Van Limbergen(Netherlands Institute for Neuroscience), Mark Löwenberg(Amsterdam University Medical Centers), Tim G. J. de Meij(Emma Kinderziekenhuis), Geert D’Haens(Amsterdam University Medical Centers), Charlotte M. Verburgt(Emma Kinderziekenhuis), Rotem Sigall Boneh(University of Amsterdam), K Gecse(Amsterdam University Medical Centers), Eytan Wine(University of Alberta), Wouter J. de Jonge(University of Bonn), N van der Kruk(Emma Kinderziekenhuis), Joep P. M. Derikx(Amsterdam Institute for Global Health and Development)
Cited by 1
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
|Nature Immunology|2005|1.1k
Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel Disease
|Gastroenterology|2008|957
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
|Gastroenterology|1998|865